TCL Archive Von Eschenbach says he will continue as NCI director and give both jobs “100 percent.” September 30, 2005
TCL Archive FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer April 29, 1988
